Search for:
Category

Hungary

Category
In Cybersecurity, Data and Tech

Hungary: Software procurement – Considerations to prevent legal problems

by 5 Mins Read

Digital transformation has become a priority for all major companies. This is being driven only further by the spread of artificial intelligence’s commercial use cases and ever-tightening data protection and cybersecurity regulations. However, procuring enterprise software (concerning both the development of custom-made software and “off-the-shelf” software developed for mass use) may give rise to various legal issues. Promptly identifying and addressing these issues can help prevent considerable legal and operational expenses, as well as other inconveniences.

Read More
In Employment

Hungary: Restrictions on the employment of migrant workers

by and 3 Mins Read

Starting 1 January 2025, only citizens of Georgia and Armenia will be eligible for residence permits for the purpose of employment and guest worker residence permits. This marks a significant tightening of the previous rules, which allowed citizens of 10 countries to obtain guest worker residence permits and had no such restrictions for residence permits for the purpose of employment. Although these changes do not affect currently valid permits, the new rules will apply to all new permit issuances.

In Cybersecurity, Data and Tech

Hungary: Hungarian Cybersecurity requirements

by and 3 Mins Read

The Hungarian Government has published a new draft decree, which, once adopted, will establish new fines for failure to provide data, either within the deadline or at all, that is necessary for the registration of organizations under Act XXIII of 2023 on Cybersecurity Certification and Cybersecurity Supervision (“Cyber-certification Act”), which is the Hungarian transposition of the NIS2 Directive [Directive (EU) 2022/2555]. For numerous organizations, the above-mentioned deadline was 30 June 2024.

In Product Regulation & Liability

Hungary: Pharmaceutical law developments

by and 4 Mins Read

Under the recently published Act XXIX of 2024 amending certain acts concerning the operation of the State, as of 1 January 2025, certain decisions on named patient reimbursement of medicinal products will be made by a newly created public benefit foundation in addition to the NEAK. Further, starting from 1 January 2026, the operator of the National eHealth Infrastructure (EESZT) may give access to the stored data for the purpose of AI development.

Read More
In Employment

Hungary: Employment supervisory inspections – experiences and risks

by and 3 Mins Read

The employment supervisory authority has published its annual report summarizing its findings from inspections carried out over 2023. The main objective of the inspections was to assess the extent to which employers comply with the basic rules on employment. We highlight the most important takeaways of the authority’s report and our expectations for the future.

In Anti-Corruption

Hungary: Authorities stress the importance of the fairness of public procurements

by 4 Mins Read

Technical guidance published on the websites of the Hungarian Competition Authority (HCA) and the Public Procurement Authority in November 2023 on corruption risks and cartel agreements affecting the fairness of public procurements. The guidance aims to both raise awareness among contracting authorities on how to ensure the most effective competition…

Read More
In Product Regulation & Liability

Hungary: National Public Health and Pharmaceutical Center established

by 7 Mins Read

As of 1 August 2023, the National Institute of Pharmacy and Nutrition will be merged into the National Public Health Center. The resulting new authority will be called the National Public Health and Pharmaceutical Center (NNGYK).
The new authority will be headed by the Chief Medical Officer, and in terms of administrative hierarchy, the NNGYK will be under the supervision of the Minister of the Interior, acting in the capacity of Minister responsible for Health.

In Product Regulation & Liability

Hungary: Reforms aiming to remove hurdles to late market access of innovative pharmaceuticals

by 3 Mins Read

Reimbursing medicinal products is critical to ensure that treatments are widely available to patients. This is especially true for innovative products and is expected to become even more important with the EU Pharma reform package. Pricing and reimbursement (P&R) is an area regulated at Member State level, and on average the regulatory approach in Hungary has been on the stricter side for new medicinal products causing delay to market access. However recent legal reforms in Hungary on P&R aim to improve the situation and ensure earlier access for patients to innovative medicines.

In ESG

European Union: Commission tables proposal for Green Claims Directive

by , and 6 Mins Read

On 22 March 2023, the European Commission tabled a proposal for a Directive on substantiation and communication of explicit environmental claims.
The proposal aims to harmonize the evaluation and monitoring of voluntary environmental claims – often referred to as “green claims” – towards EU consumers and control the proliferation of public and private environmental labels. Complementing the March 2022 proposal for a Directive on empowering consumers for the green transition as a lex specialis by providing more specific requirements on the substantiation, communication and verification of green claims, it contributes to the fight against “greenwashing”.

Read More
Load More